Trial Profile
Using an Internet Study to Improve Adherence for Psoriasis Patients
Status:
Completed
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 13 Nov 2019
Price :
$35
*
At a glance
- Drugs Fluocinonide (Primary)
- Indications Psoriasis
- Focus Therapeutic Use
- 05 May 2016 Status changed from active, no longer recruiting to completed.
- 09 Dec 2015 Planned End Date changed from 1 Dec 2013 to 1 Jun 2016 as reported by ClinicalTrials.gov.
- 09 Dec 2015 Planned primary completion date changed from 1 Jun 2015 to 1 Mar 2016 as reported by ClinicalTrials.gov.